Back to Search
Briellyn
by Glenmark Pharmaceuticals Inc., USAContraceptionCOCP
Actively PrescribedGeneric

Estrogen

Ethinyl Estradiol

0.035Mg

Progestin

Norethindrone

0.4Mg

Regimen Protocol

Monophasic 28 day

Androgenicity

Moderate

Approval Date

3/22/2011

Additives
None
Inactive Ingredients
anhydrous lactoselactose monohydratepregelatinized starchcolloidal silicon dioxidedibasic calcium phosphate dihydrateFD&C Yellow No. 6 Aluminum Lakemagnesium stearatepovidonesodium starch glycolatetalc

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Barr Laboratories Inc

Balziva-28
Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Endo Operations Ltd

Gildagia

Aurobindo Pharma Limited

Nexesta Fe

Watson Laboratories Inc

Norethindrone And Ethinyl Estradiol

Amneal Pharmaceuticals Of New York Llc

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Lupin Ltd

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Naari Pte Ltd

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Xiromed Llc

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Northstar Rx LLC

Philith

Lupin Pharmaceuticals, Inc.

Vyfemla
Wymzya Fe

Amneal Pharmaceuticals NY LLC

Zenchent Fe

Teva Pharmaceuticals Usa Inc.

Zeosa Fe

Have clinical questions about Briellyn?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy